EyeYon Medical

Call Directions Website Contact the business

EyeYon Medical EyeYon Medical is a start-up company specialized in developing medical ophthalmic devices, which off Its innovative technologies are proven in clinical studies.

EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to unmet clinical need for millions of patients. EyeYon’s first product, Hyper-CL™, a therapeutic contact lens for treating corneal edema, has received the CE Mark and FDA 510(k) clearance, and is approved for marketing in Europe, the USA and additional territories. EyeYon’s future product, the EndoArt® is an artificial endothelial layer that cures corneal edema using an implant made of silicon film attached to the posterior corneal surface. The EndoArt® is in pre-clinical stage and has demonstrated promising results in animal trials.

Wishing our colleagues, partners, surgeons, and friends in the United States a very happy 4th of July.Today is an opport...
04/07/2026

Wishing our colleagues, partners, surgeons, and friends in the United States a very happy 4th of July.

Today is an opportunity to celebrate 250 years of independence, innovation, and the continued pursuit of progress, values that strongly resonate with us at EyeYon Medical.

From all of us at EyeYon, we wish you a joyful Independence Day.

Great to see EyeYon Medical represented today at the AECOS (American-European Congress of Ophthalmic Surgery) 2026 Europ...
11/06/2026

Great to see EyeYon Medical represented today at the AECOS (American-European Congress of Ophthalmic Surgery) 2026 Europe Symposium in Madrid, Spain.

Our CEO, Nahum Ferera, presented EyeYon’s vision and the continued development of EndoArt® as part of the discussion around the future of corneal endothelial treatment.

AECOS brings together leading voices in ophthalmic surgery, and it is always valuable to be part of conversations focused on innovation, clinical experience, and improving treatment options for patients with corneal endothelial decompensation.

Thank you to the organisers, faculty, and attendees for an excellent meeting and for the opportunity to share the EndoArt journey.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

A major milestone for EndoArt implantation number 800 We’re proud to celebrate the 800th EndoArt implantation, performed...
18/12/2025

A major milestone for EndoArt implantation number 800

We’re proud to celebrate the 800th EndoArt implantation, performed by Prof. Mor Dickman at Utrecht University Hospital. This landmark case reflects years of clinical collaboration, surgical excellence, and a shared commitment to expanding treatment options for patients with corneal endothelial disease.

Each implantation represents not just a number, but a patient, a decision to innovate, and a step forward for the field. Reaching 800 is a powerful signal of the growing clinical experience and confidence around EndoArt across leading centres worldwide.

Our sincere thanks to Prof. Dickman and the Utrecht team for their continued leadership and contribution to this journey. Here’s to the next chapter — and the next milestones ahead.

16/12/2025

A Christmas Message from EyeYon Medical & our CEO, Nahum Ferera.

As we approach the end of another remarkable year, we want to send our warmest holiday wishes to our partners, colleagues, clinicians, and friends around the world.

2025 has been a year of meaningful progress for EyeYon Medical. With every cornea we help preserve, every patient whose vision is restored, and every clinic we support with EndoArt®, we are reminded why our mission matters so deeply.

To our global EyeYon Medical family thank you.

Your trust, collaboration, and belief in innovation continue to drive us forward.

On behalf of the EyeYon Medical team, we wish you a joyful Christmas, a restorative holiday season, and a bright start to the New Year.

Here’s to making clear vision possible for even more patients in 2026.
Happy Holidays!

hashtag

🌟 A New Hope for Patients Across Europe! 🌟This week EndoArt® lands in 6 new clinical sites, with new surgeons successful...
19/11/2025

🌟 A New Hope for Patients Across Europe! 🌟

This week EndoArt® lands in 6 new clinical sites, with new surgeons successfully implanting EndoArt and bringing a new hope to patients in Italy, France, and Germany.

Every new site means more people gaining access to a breakthrough, innovative device for chronic corneal edema. We’re proud to see the EndoArt community grow and grateful to the surgeons and clinical teams who are championing innovation in corneal care.

🇮🇹 🇫🇷 🇩🇪
Here’s to expanding access, empowering clinicians, and transforming patients’ lives one implant at a time.

EndoArt® A New Hope for Corneal Patients

EyeYon medical with be at the UKISCRS society meeting next week. We hope to see all the UK corneal specialists there.
06/11/2025

EyeYon medical with be at the UKISCRS society meeting next week. We hope to see all the UK corneal specialists there.

EyeYon Medical will be at this years American Academy of Ophthalmology meeting, October 18–20 in Orlando, Florida.  Plea...
17/10/2025

EyeYon Medical will be at this years American Academy of Ophthalmology meeting, October 18–20 in Orlando, Florida.

Please be sure to attend the Cornea, External Disease Original Papers session on Monday, October 20, 2025, 09:45 – 11:00 am where Prof. Jod Mehta, from the Singapore National Eye Centre, is presenting.

Presentation title: Long-Term Outcomes of Artificial Endothelial Replacement Implant, EndoArt®, in Chronic Corneal Edema Patients, Including Patients at High-Risk for Human Tissue Rejection
Time: Monday, October 20, 2025, 10:45 am

If you are attending AAO and want arrange a meeting to discuss EndoArt®, contact [email protected]

https://lnkd.in/eTJ3Y4sK

In attendance will be Ofer Daphnah, Nahum Ferera, Limor Leifenberg Kuznits, Robert Warner from EyeYon Medical.

Here’s to advancing vision care and giving A New Hope to patients everywhere, together.

Another opportunity to watch the cornea discussion from   featuring Prof. Peter Szurman. The EndoArt® segment begins at ...
07/10/2025

Another opportunity to watch the cornea discussion from featuring Prof. Peter Szurman. The EndoArt® segment begins at 1:41 and provides valuable real-world insights into how patients and the EndoArt perform in complex eyes, including cases involving silicone oil and retinal complications.

https://youtu.be/1oE_c3rsPmQ?si=0nVsYo5qa3WCpzCE

For more information on how you can introduce EndoArt® into your patient toolbox please reach out to:

Nicholas Helme - [email protected] - Germany and Austria
Lauren Jackson - [email protected] - Northern UK, France, Belgium, Netherlands, Italy and Portugal
Jake Blackwell - [email protected] - Southern UK, Spain, Switzerland and Nordics

Aufzeichnung der Sulzbacher Hornhaut Expert Debate vom 27. August 2025 zum Thema: Aktuelle Innovationen zur Behandlung schwerer Hornhauterkrankungen.Kompakte...

Read all about Prof. Luis Fernandez Vega’s near live surgery with Cake Magazines review of the session from the  in Cope...
03/10/2025

Read all about Prof. Luis Fernandez Vega’s near live surgery with Cake Magazines review of the session from the in Copenhagen here.

Sponsored by EyeYon Medical By combining ease of implantation with safe and predictable visual outcomes, EndoArt® is redefining what’s possible...

✨ Two years ago at the Ophthalmology Futures Forum, EyeYon Medical  proudly launched EndoArt® — the world’s first artifi...
30/09/2025

✨ Two years ago at the Ophthalmology Futures Forum, EyeYon Medical proudly launched EndoArt® — the world’s first artificial endothelial layer for the treatment of corneal edema.

During the Ophthalmology Futures Forum in Copenhagen, our CEO Nahum Ferera returned to the stage to share the journey since that moment. With over 600 successful EndoArt implantations and growing momentum across a limited market release, he provides an update on the global success, rising demand, and future vision for this breakthrough technology.

EndoArt is already transforming corneal care — and this is only the beginning. 🌍👁️

We invite our peers, partners, and the wider ophthalmology community to watch the session and hear first-hand how EyeYon is shaping the future of corneal therapy.



This link will take you to a page that’s not on LinkedIn

Address

3 Golda Meir
Ness Ziona
7403649

Alerts

Be the first to know and let us send you an email when EyeYon Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EyeYon Medical:

Shortcuts

Share




Enable notifications